These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9914338)

  • 21. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
    Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
    Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response of mice to Thy-1. 1 antigen: genetic control by alleles at the Ir-5 locus loosely linked to the H-2 complex.
    Zaleski M; Klein J
    J Immunol; 1974 Oct; 113(4):1170-7. PubMed ID: 4606643
    [No Abstract]   [Full Text] [Related]  

  • 23. Iron deficiency and in vitro iron chelation reduce the expression of cluster of differentiation molecule (CD)28 but not CD3 receptors on murine thymocytes and spleen cells.
    Kuvibidila SR; Porretta C
    Br J Nutr; 2003 Jul; 90(1):179-89. PubMed ID: 12844390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docosahexaenoic and eicosapentaenoic acids inhibit the CD28-lymphocyte activation pathway in vitro.
    Khalfoun B; Sibué D; Bardos P; Lebranchu Y
    Transplant Proc; 1998 Dec; 30(8):3978-9. PubMed ID: 9865267
    [No Abstract]   [Full Text] [Related]  

  • 25. Age- and strain-related differences in murine spleen cell responses to different activation signals.
    Kariv I; Ferguson FG; Confer FL
    Cell Immunol; 1992 Mar; 140(1):67-80. PubMed ID: 1531455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of enteric functional changes evoked by in vivo anti-CD3 T cell activation.
    Radojevic N; McKay DM; Merger M; Vallance BA; Collins SM; Croitoru K
    Am J Physiol; 1999 Mar; 276(3):R715-23. PubMed ID: 10070131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An integrated genetic map of the pearl locus of mouse chromosome 13.
    Seymour AB; Yanak BL; O'Brien EP; Rusiniak ME; Novak EK; Pinto LH; Swank RT; Gorin MB
    Genome Res; 1996 Jun; 6(6):538-44. PubMed ID: 8828042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responses.
    Ridgway WM
    Rev Endocr Metab Disord; 2003 Sep; 4(3):263-9. PubMed ID: 14501177
    [No Abstract]   [Full Text] [Related]  

  • 29. CD28 costimulation induces delta opioid receptor expression during anti-CD3 activation of T cells.
    Nguyen K; Miller BC
    J Immunol; 2002 May; 168(9):4440-5. PubMed ID: 11970987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice.
    Beamer WG; Shultz KL; Donahue LR; Churchill GA; Sen S; Wergedal JR; Baylink DJ; Rosen CJ
    J Bone Miner Res; 2001 Jul; 16(7):1195-206. PubMed ID: 11450694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired cutaneous immune responses in Thy-1-deficient mice.
    Beissert S; He HT; Hueber AO; Lellouch AC; Metze D; Mehling A; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1998 Nov; 161(10):5296-302. PubMed ID: 9820502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen presentation in the murine T-lymphocyte proliferative response. I. Requirement for genetic identity at the major histocompatibility complex.
    Yano A; Schwartz RH; Paul WE
    J Exp Med; 1977 Sep; 146(3):828-43. PubMed ID: 70497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A proteasome inhibitor effectively prevents mouse heart allograft rejection.
    Luo H; Wu Y; Qi S; Wan X; Chen H; Wu J
    Transplantation; 2001 Jul; 72(2):196-202. PubMed ID: 11477338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2.
    Holán V; Lipoldová M; Demant P
    Immunogenetics; 1996; 44(1):27-35. PubMed ID: 8613140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine lymphocyte alloantigens. I. The Ly-6 locus.
    Potter TA; McKenzie IF; Morgan GM; Cherry M
    J Immunol; 1980 Aug; 125(2):541-5. PubMed ID: 6156206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro T cell unresponsiveness following low-dose injection of anti-CD3 MoAb.
    Ben-Amor A; Leite-De-Moraes MC; Lepault F; Schneider E; Machavoine F; Arnould A; Chatenoud L; DY M
    Clin Exp Immunol; 1996 Mar; 103(3):491-8. PubMed ID: 8608651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice.
    Prochazka M; Serreze DV; Frankel WN; Leiter EH
    Diabetes; 1992 Jan; 41(1):98-106. PubMed ID: 1727742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3h/HeJ inbred strains of mice. (2001).
    Beamer WG; Shultz KL; Donahue LR; Churchill GA; Sen S; Wergedal JR; Baylink DJ; Rosen CJ
    J Bone Miner Res; 2005 Sep; 20(9):1701-12; discussion 1700. PubMed ID: 16220609
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune alterations in three mouse strains following 2-deoxy-D-glucose administration.
    Dréau D; Foster M; Morton DS; Fowler N; Kinney K; Sonnenfeld G
    Physiol Behav; 2000 Sep; 70(5):513-20. PubMed ID: 11111005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses.
    Nishimura H; Minato N; Nakano T; Honjo T
    Int Immunol; 1998 Oct; 10(10):1563-72. PubMed ID: 9796923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.